DC Field | Value | Language |
dc.contributor.author | Voronkov, A. V. | - |
dc.contributor.author | Pozdnyakov, D. I. | - |
dc.date.accessioned | 2022-04-27T13:08:22Z | - |
dc.date.available | 2022-04-27T13:08:22Z | - |
dc.date.issued | 2018 | - |
dc.identifier.citation | Voronkov, A.V. Endothelotropic activity of 4-hydroxy-3,5-di-tret-butylcinnamic acid in the conditions of experimental cerebral ischemia / A.V. Voronkov, D.I. Pozdnyakov // Research result: pharmacology and clinical pharmacology. - 2018. - Vol. 4, № 2.- P. 1-10. - DOI: 10.3897/rrpharmacology.4.26519. | ru |
dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46409 | - |
dc.description.abstract | The aim of the study was to evaluate the endothelioprotective activity of 4-hydroxy-3,5-di-tret-butylcinnamic acid in conditions of experimental cerebral ischemia. The brain ischemia was reproduced by the method of irreversible right-sided thermocoagulation of the middle cerebral artery. As comparative drugs, mexidol (30 mg/kg) and sulodexide (30 U/kg) were used | ru |
dc.language.iso | en | ru |
dc.subject | medicine | ru |
dc.subject | pharmacology | ru |
dc.subject | ischemic stroke | ru |
dc.subject | cerebral ischemia | ru |
dc.subject | endothelial dysfunction | ru |
dc.subject | cinnamic acid derivatives | ru |
dc.title | Endothelotropic activity of 4-hydroxy-3,5-di-tret-butylcinnamic acid in the conditions of experimental cerebral ischemia | ru |
dc.type | Article | ru |
Appears in Collections: | Vol. 4, № 2
|